Dr Christophe Willekens
- Specialty
- Hematologist, myeloma and leukemia expert
- Hospital
- Gustave Roussy (Villejuif)
- Latest articles
-
- Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. (Feb 25, 2025)
- Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023. (Jan 1, 2025)
- Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19. (Nov 1, 2024)
- CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia. (Sep 17, 2024)
- RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives. (Apr 24, 2024)